By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Eisai Company, Ltd. 

4-6-10 Koishikawa, Bunkyo-ku

Tokyo    112-8088  Japan
Phone: 81-3-3817-3700 Fax: n/a


SEARCH JOBS


Key Statistics


Email: webmaster@eisai.co.jp
Ownership: Public

Web Site: Eisai Company
Employees: 7,043
Symbol: ESALY.PK
 





Collaborations

IDEC Pharma 

BioVeris Corporation 





Company News
MPI: Oncology Venture And Eisai Company (ESALY.PK) Forge Exclusive Global License Agreement For Clinical Stage Oncology Drug PARP Inhibitor E7449 - 2X-121 7/7/2017 10:05:46 AM
Wellness Open Living Labs. LLC, Co-Founded By Eisai Company (ESALY.PK) And Osaka City University Conclude Basic Collaboration Agreement Aimed At Solving Health Problems 7/5/2017 11:14:15 AM
Eisai Company (ESALY.PK) And Ewopharma Announce Commercial Partnership In Central Eastern Europe For Halaven, Targretin And Zonegran 6/23/2017 8:21:36 AM
Eisai Company (ESALY.PK) To Present Results Of Phase Ib/II Study Of Anticancer Agent Lenvima (Lenvatinib) In Combination With Anti-PD-1 Antibody Pembrolizumab 6/5/2017 5:03:03 PM
Eisai Company (ESALY.PK) Presents Data Of Mechanisms Of Action Relating To Tumor Immune Response Regarding Combination Of Anticancer Agent Lenvatinib With Anti-PD-1 Antibody At AACR 108th Annual Meeting 4/5/2017 11:22:01 AM
Meiji Seika Pharma And Eisai Company (ESALY.PK) Enter Into A Collaboration For The Development And Commercialization Of Safinamide In Parkinson’s Disease For Japan And Asia 4/5/2017 8:13:09 AM
Eisai Company (ESALY.PK) To Launch Smell Identification Test UPSIT Series In Japan 4/4/2017 3:10:35 PM
Eisai Company (ESALY.PK) Release: Transfer Of Rights To Insomia Treatment / Anaesthesia Induction Agent Flunitrazepam In Japan 1/16/2017 11:35:00 AM
Eisai Company (ESALY.PK) Release: Pharma To Launch Medication Administration Support Device 1/12/2017 9:03:52 AM
Eisai Company (ESALY.PK) Release: Anticancer Agent Treakisym Approved In Japan For Additional Indication As First-Line Treatment For Low-Grade B-Cell Non-Hodgkin's Lymphoma And Mantle Cell Lymphoma 12/22/2016 12:56:15 PM
12345678910...
//-->